BETA

8 Amendments of Karin KADENBACH related to 2014/2207(INI)

Amendment 82 #
Motion for a resolution
Recital Q
Q. whereas it is of paramount importance to encourage pharmaceutical companies to invest in developing new antibiotic compounds, in particular with activity against prevalent multidrug-resistant Gram-negative bacteria such as K. pneumoniae and Acinetobacter;Does not affect the English version.
2015/03/09
Committee: ENVI
Amendment 185 #
Motion for a resolution
Paragraph 15
15. Welcomes the Commission’s work on antimicrobial resistance and on the prevention and control of HAIs, as well as the coordination and surveillance efforts of the European Centre for Disease Prevention and Control (ECDC);Does not affect the English version.
2015/03/09
Committee: ENVI
Amendment 190 #
Motion for a resolution
Paragraph 17
17. Notes with concern that between 2010 and 2013 the percentages of K. pneumoniae resistant to fluoroquinolones, third-generation cephalosporins and aminoglycosides, as well as combined resistance to all three antibiotic groups, significantly increased in many Member States and at EU level; further notes that during the same period resistance to third- generation cephalosporins also significantly increased in many Member States and at EU level for E. coli;Does not affect the English version.
2015/03/09
Committee: ENVI
Amendment 202 #
Motion for a resolution
Paragraph 19
19. Welcomes and encourages further research for new antimicrobial drugs, in particular antibiotics with activity against prevalent multidrug-resistant Gram- negative bacteria such as K. pneumoniae and Acinetobacter, as well as for alternative methods aimed at fighting HAIs without using antibiotics;Does not affect the English version.
2015/03/09
Committee: ENVI
Amendment 236 #
Motion for a resolution
Paragraph 22 – point a
(a) regulate the prescription of antibiotics for treatment or prophylaxis so that an appropriate use of medicines is ensured, specifying the therapeutic and preventive objective and selecting the appropriate drug therapy;
2015/03/09
Committee: ENVI
Amendment 244 #
Motion for a resolution
Paragraph 22 – point b
(b) regulate the sale of antibiotics so that patients can buy only the specific quantity of antibiotics as prescribed by their doctors, as, in some Member States, rules exist which prohibit the sale of antibiotics in quantities limited at the time of packaging to the quantities specified for consumption in patient care plans;
2015/03/09
Committee: ENVI
Amendment 279 #
Motion for a resolution
Paragraph 23 – point a
(a) PromotIncrease the responsible and sensible use in veterinary medicine of all antimicrobial agents and in particular antibiotics that are critically important in human medicine, such as fluoroquinolones and third- and -fourth generation cephalosporin;
2015/03/09
Committee: ENVI
Amendment 308 #
Motion for a resolution
Paragraph 25 – indent 1
to adopt provisions aimed at banning or limiting the off-label use in animals of certain antimicrobials authorised only in human medicine, following a risk assessment of such use;
2015/03/09
Committee: ENVI